Process for the production of atorvastatin calcium in...

Details Process for the production of atorvastatin calcium in... Process for the production of atorvastatin calcium in...

2011-08-09

2011-08-09

Nolan, Jason M (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07994343

ABSTRACT:
A process for the production of amorphous atorvastatin calcium and stabilized, amorphous atorvastatin calcium is provided.

REFERENCES:
patent: 5003080 (1991-03-01), Butler et al.
patent: 5097045 (1992-03-01), Butler et al.
patent: 5103024 (1992-04-01), Millar et al.
patent: 5124482 (1992-06-01), Butler et al.
patent: 5149837 (1992-09-01), Butler et al.
patent: 5155251 (1992-10-01), Butler et al.
patent: 5216174 (1993-06-01), Butler et al.
patent: 5245047 (1993-09-01), Butler et al.
patent: 5248793 (1993-09-01), Millar et al.
patent: 5273995 (1993-12-01), Roth
patent: 5280126 (1994-01-01), Butler et al.
patent: 5342952 (1994-08-01), Butler et al.
patent: 5397792 (1995-03-01), Butler et al.
patent: 5686104 (1997-11-01), Mills et al.
patent: 6528660 (2003-03-01), Kumar et al.
patent: 6613916 (2003-09-01), Pflaum
patent: 6646133 (2003-11-01), Greff et al.
patent: 2002/0183378 (2002-12-01), Aronhime et al.
patent: 2003/0109569 (2003-06-01), Sorsak
patent: 2004/0077708 (2004-04-01), Grahek et al.
patent: 2392025 (2001-06-01), None
patent: 2456095 (2003-03-01), None
patent: 1 148 049 (2001-10-01), None
patent: WO 97/03960 (1997-02-01), None
patent: WO 00/71116 (2000-11-01), None
patent: WO 01/28999 (2001-04-01), None
patent: WO 01/42209 (2001-06-01), None
patent: WO 01/93860 (2001-12-01), None
patent: WO 02/41834 (2002-05-01), None
patent: WO 02/051804 (2002-07-01), None
patent: WO 02/057225 (2002-07-01), None
patent: WO 02/057228 (2002-07-01), None
patent: WO 02/083637 (2002-10-01), None
patent: WO 02/083638 (2002-10-01), None
patent: WO 03/004470 (2003-01-01), None
patent: WO 03/011826 (2003-02-01), None
patent: WO 03/018547 (2003-03-01), None
patent: WO 03/068739 (2003-08-01), None
patent: WO 03/078379 (2003-09-01), None
patent: WO 03/099785 (2003-12-01), None
patent: WO 2004/085391 (2004-10-01), None
patent: WO 2006/037125 (2006-04-01), None
Pavia et al. Introduction to Organic Laboratory Techniques 1990, pp. 577-596.
Brower et al, “The Synthesis of (4R-cis)-1,1-Dimethylethyl 6-cyanomethy1-2,2-dimethyl-1,3-dioxane-4-acetate, a Key Intermediate for the Preparation of CI-981, a Highly Potent, Tissue Selective Inhibitor of HMG-CoA Reductase”,Tetrahedron Letters, 33(17):2279-2282 (1992).
Shimako et al, “Atorvastatin (CI-981) Clinical Pharmacokinetic Study (I): Relative Bioavailability of Amorphous and Crystalline Preparations of Atorvastatin”,Japanese Pharmacology and Therapeutics, 26(8):1241-1252 (1998).
Wade et al., “In Pursuit of Higher Purity: Use of13C NMR and13C-Enriched Substrates to Trace Impurity Generation and Removal in the Synthesis of Atorvastatin”,Organic Process Research and Development, 1(4):320-324 (1997).

Affiliated with

Also associated with

Rating

Process for the production of atorvastatin calcium in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for the production of atorvastatin calcium in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the production of atorvastatin calcium in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2723029